HR 1427 Promotoing Innovation and Access to Life-Saving Medicne Act; (all relating to follow-on biologics.) S 515 A bill to amend title 35, US Code to provice for patent reform; (Sect. 4; Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisions related to Post Grant Procedures.) Appropriations (no bill numbers) Seeking funding for the FY 2011 appropriations bills; (All provisions related to agriculture research funding, food security issues, and funding of USDA agencies including APHIS and FAS, EPA and pesticide fees) HR 2454 the American Clean Energy and Security Act of 2009; (A bill to create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions pertaining to the advancement of a Cap and Trade greenhouse gas reducion system and energy efficiency measures.) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.)
HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs.)
HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs.) HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism agains chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.) S 1462 American Clean Energy Leadership Act of 2009; (A bill to promote clean energy technology development; (All provisions related to enhanced energy efficiency and clean energy development.) HR 6228/S 593 The Ban Poisonous Act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.)

HR 4341 Bisphenol-A consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)

HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)

S 510 Food Safety Modernization Act, a bill to modernize the Food and Drug Administrations regulation of food safety; (All provisions related to adding an amendment on Bisphenol-A.)

HR 1332 Safe FEAST Act of 2009, a bill to empower the Food and Drug Administration to more thoroughly protect the food supply; (All provisions relating to BPA.)

S 510 Food Safety and Modernization Act; (All sections.) HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) HR 2999 Veterinary Public Health Workforce and Education Act;(In support for legislation.)
HR 3519/S1709 Veterinary Services Investment Act; (Support legislation.) HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.) HR 233 The Railroad Antitrust Enforcement Act of 2009, a bill to amend Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.) S 146 Railroaad Anti-Trust Enforcement Act, a bill to amend the Federal anti-trust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (All provisions pertaining to the "common carrier" provisions of the Staggers Act and injunctive relief for exemptions contrary to the public interest.)

S 2889 Surface Transportation Reauthorization Act 2009, a bill to reauthorize the Surface Trasportation Act and for other purposes; (All provisions related to bottleneck provisions, common carrier, injunctive relief, rate quotation, competition, and service necessary to business and public interest.) HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.)
HR 4394 Decabromine Elimination and Control Act; (Strategy for input into the bill.) HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.)
HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety. Monitoring food safety provisions.) HR 2400 Strategies to address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.) HR 2438 To amend the Internal Revenue Code of 1986 to provide temporary bonus research credit for energy related research; (all provisions pertaining to inherently safer technology, citizen suits and information disclosure.)
HR 598 American Recovery and Reinvestment Act of 2009, a bill to expand the research and development tax credit for energy research expenses related to fuel cells, battery technology, renewable energy and carbon capture and sequestration; (All provisions related to research and development.)

Protocol Number HP-1350 US France protocol to Incomve Tax Treaty; (Provisions relating to entire bill.)

S 1631 Customs Reauthorization Act; (Strategy and input on the bill for Senate Finance staff.) HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.)

HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.)

HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.)

HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.)

HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.)

HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.)

HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.)

HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.)

S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.)

HR 1321 Healthy Americans Act; (Relating to Medicare)

Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.)

HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare; all provisions related to competitive acquisition for durable medical equipment and prosthetics, orthotics, and supplies.).)

HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.)

HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) 

S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

HR 3790 To Amend Title XVIII of the Social Security Act to repeal the Medicare competitive aquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); (All provisions related to competitive acquistionf for durable medical equipment and prosthetics, orthotcs, and supplies.) HR 1321 Healthy Americans Act; (Provisions relating to Medicare)
Senate Finance Committee Chairman's Mark, America's healthy Future Act of 2009; (All provisions.)
HR 3962 Affordable health Care for America Act; (Sections relating to health insurance and drugs.) HR 3790 To Amend Title XVIII of the Social Security Act to repeal the Medicare competitive aquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); (All provisions related to competitive acquistionf for durable medical equipment and prosthetics, orthotcs, and supplies.)

HR 3590 Patient Protection and Affordable Care Act of 2010; (All provisions related to competitive acquisition for durable medical equipment and prosthetics, orthotics, and supplies.) HR 4380- Miscellaneous Tariff Bill, to amend the Harmonized Tariff Schedule and temporarily suspend  or modify current rates of tariff; (All provisions related to the tariff bills introduced below):
A bill to extend the temporary suspension of duty on o-Acetylsalicylic acid (Aspirin). 
A bill to suspend temporarily the duty on Propoxur (Sedran Technical). S 2712 A bill to extend the temporary suspension of duty on D-Mannose

S 2169 A bill to extend the suspension of duty on Mixtures of Methyl o-toluenesulonate and methyl p-toluenesulfonate (TSME). 

S 2169 A bill to extend the suspension of duty on Trimethylopropane tris(3-aziridinylpropanoate)  (Xama 2)  

2166 A bill to extend the suspension of duty on Polyfunctional aziridine (Xama 7). 

S 2187 A bill to extend the suspension of duty on 1,3-Diisocyanatomethylbenzene, polymer with 1,6-diisocyanatohexane (Desmondur VP HL). 

S 2189 A bill to extend the suspension of duty on A linear aromatic polyurethane prepolymer based on toluene diisocyanate. (Desmondur E 14

S 2188 A bill to extend the suspension of duty on Poly(toluene diisocyanate)  (Desmondur IL BA). 

S 2190 A bill to extend the suspension of duty on Polyisocyanate cross linking agent products containing triphenylmethane triisocyanate in solvents, (Desmondur R-E). 

S 2185 A bill to extend suspension of duty on Mixtures of tris(4-isocyanatophenyl)thiophosphate) in solvents, (Desmondur RF-E). 

S 2167 A bill to extend the suspension of duty on hexane 1,6, diisocynato-, homopolymer, 3,5, dimethyl-1H-pyrazole-blocked solvents.( Desmodur VP LS 2253)

S2186 A bill to extend the suspension of duty on Copolymer of methyl ethyl ketoximine and toluene diisocyanate (Desmondur BL XP). 

S 2165) A bill to extend the suspension of duty on 2-Oxepanone polymer with 1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1-hexanol-blocked (Crelan). HR 3790 To Amend Title XVIII of the Social Security Act to repeal the Medicare competitive aquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); (All provisions related to competitive acquistionf for durable medical equipment and prosthetics, orthotcs, and supplies.) HR 3590 Patient Protection and Affordable Care Act of 2010; (All provisions related to competitive acquisition for durable medical equipment and prosthetics, orthotics, and supplies.) S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changeing the definition of U.S. Waters.)
PHA - Pharmacy CPT - Copyright/Patent/Trademark BUD - Budget/Appropriations ENV - Environment/Superfund INS - Insurance CHM - Chemicals/Chemical Industry ENG - Energy/Nuclear FOO - Food Industry (safety, labeling, etc.) EDU - Education ANI - Animals LBR - Labor Issues/Antitrust/Workplace RRR - Railroads MAN - Manufacturing AGR - Agriculture TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid TAR - Tariff (miscellaneous tariff bills) MED - Medical/Disease Research/Clinical Labs CAW - Clean Air and Water (quality)
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAYER CORPORATION (CONSOLIDATED REPORT)
801 Pennsylvania Ave., NW Suite 900, WASHINGTON, DC, 20004, US
THOMAS B LILBURN RONALD F DOCKSAI ROBERT D THOMAS JULIE CORCORAN JEAN D REIMERS JENNIFER SPURGAT JULIANE H VAN EGMOND THOMAS B LILBURN JEAN D REIMERS JENNIFER SPURGAT JULIANE H VAN EGMOND JULIANE H VAN EGMOND RONALD F DOCKSAI DONNA STEPHENS DONNA STEPHENS ROBERT D THOMAS JULIANE H VAN EGMOND ROBERT D THOMAS KAREN NIEDERMEYER JEAN D REIMERS JENNIFER SPURGAT JULIANE H VAN EGMOND RONALD F DOCKSAI KAREN NIEDERMEYER JULIANE H VAN EGMOND DONNA STEPHENS THOMAS B LILBURN JULIE CORCORAN ROBERT D THOMAS RONALD F DOCKSAI LORI WALLACE THOMAS B LILBURN LORI WALLACE JULIANE H VAN EGMOND KAREN NIEDERMEYER LORI WALLACE JEAN D REIMERS JENNIFER SPURGAT